Old Web
English
Sign In
Acemap
>
Paper
>
SAGE-217 in major depressive disorder: A multicenter, randomized, double-blind, Phase 2 placebo-controlled trial
SAGE-217 in major depressive disorder: A multicenter, randomized, double-blind, Phase 2 placebo-controlled trial
2019
Handan Gunduz-Bruce
C. Silber
Anthony Rothschild
Robert Riesenberg
Abdul J. Sankoh
Haihong Li
E. Li
Charles F. Zorumski
David R. Rubinow
Steven M. Paul
Jeffrey M. Jonas
James Doherty
Stephen Kanes
Keywords:
Major depressive disorder
Psychiatry
Psychology
Placebo-controlled study
SAGE
double blind
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]